We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · January 11, 2021

Safety and Efficacy of TAVR With Continuation of Vitamin K Antagonists or Direct Oral Anticoagulants

JACC: Cardiovascular interventions

 

Additional Info

JACC: Cardiovascular interventions
Safety and Efficacy of Transcatheter Aortic Valve Replacement With Continuation of Vitamin K Antagonists or Direct Oral Anticoagulants
JACC Cardiovasc Interv 2020 Dec 23;[EPub Ahead of Print], M Brinkert, N Mangner, N Moriyama, et al

Further Reading